EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma. - Wikidata - thesis-toulmin - TriplyDB

EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma.

EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma.

http://www.wikidata.org/entity/Q37660295

about

Anti-EGFR function of EFEMP1 in glioma cells and patient prognosis.Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomide EFEMP1 promotes the migration and invasion of osteosarcoma via MMP-2 with induction by AEG-1 via NF-κB signaling pathway.Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study.Therapeutic effect of TMZ-POH on human nasopharyngeal carcinoma depends on reactive oxygen species accumulation.GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment.NOTCH blockade combined with radiation therapy and temozolomide prolongs survival of orthotopic glioblastoma.MicroRNA-564 is downregulated in glioblastoma and inhibited proliferation and invasion of glioblastoma cells by targeting TGF-β1.Notching on Cancer's Door: Notch Signaling in Brain Tumors.Sensitivity of non-small cell lung cancer to erlotinib is regulated by the Notch/miR-223/FBXW7 pathway.The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma.Identification of temozolomide resistance factors in glioblastoma via integrative miRNA/mRNA regulatory network analysis Tumor-derived fibulin-3 activates pro-invasive NF-κB signaling in glioblastoma cells and their microenvironment.A map of human circular RNAs in clinically relevant tissues.Development of a Function-Blocking Antibody Against Fibulin-3 as a Targeted Reagent for Glioblastoma.Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype.Glycosylated extracellular vesicles released by glioblastoma cells are decorated by CCL18 allowing for cellular uptake via chemokine receptor CCR8.

P2860

Q34781171-15088FDB-6001-4C69-A8BD-7F3B5CA954A7 Q34786598-B2882A7B-EE09-414C-AFCF-09FEF331DB46 Q35987298-7B88F1C4-1300-417E-84C9-8B66098EBDFC Q36378403-D27786BB-2503-4884-814E-DB64C0DA0BDF Q36738925-4993919E-22E6-46E9-8170-76B07143F7BB Q37450330-D4FFA319-64D0-469A-B97A-D703C4C5DECA Q37520199-9A4FD1C7-20BF-4EF5-950A-F4E8CEC37132 Q37636608-94B8B8A7-BC1B-4BE0-A4FD-28E20F22CF7D Q38324552-F0D15419-8C48-4E90-83C3-5D58CFE6AE75 Q38703410-0A4B71F1-74CB-4198-B946-A386CB5F3AB0 Q38819651-FFB70087-ECB9-494B-BBA3-5332C3BBA6AE Q38985855-2D5BB2E9-461C-41A1-8E82-85E6070BBE91 Q42349929-9DE3B91D-43E5-4C1E-AAEC-FB837A5A7C1B Q43061380-41485B85-2019-49BF-B198-6F6461595967 Q47965779-473DC66A-F83D-44E7-9759-55F9B2EA3E77 Q47988508-2A00B5E2-FF64-4ECD-A9AE-54CB28880BD4 Q52562611-8B5421E6-A3AD-4705-901D-506E209E811B

P2860

EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma.

http://www.wikidata.org/entity/Q37660295

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma.

@en

EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma.

@nl

type

label

EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma.

@en

EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma.

@nl

prefLabel

EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma.

@en

EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma.

@nl

P1433

Q37660295-3D3A0667-9D81-4E6C-9BAB-24D14BD40E97

P1476

Q37660295-BC0A3B1D-3B99-40D3-BA2C-4B25EBF2E9F1

P2093

Q37660295-24DAAE54-9465-49F0-BDF6-79B2F76B1261

Q37660295-2CA8C1F4-1FFD-476F-9F6F-0AB1FF3D333A

Q37660295-3A077868-A7FB-4FB3-ADC1-312880490EE8

Q37660295-4920AD02-8C7B-4E61-A3C5-D75595E6E311

Q37660295-519F7B79-2C46-4602-975F-CC265ACCAF76

Q37660295-781A1DE5-CFC4-4873-A45B-3F209991027B

Q37660295-7AB66C8A-18C1-4801-8282-6063E4EBDD3E

Q37660295-8F5F0654-288A-4AE1-903E-18C757367E82

Q37660295-9DC48B71-D976-4773-A94D-3D50B1D44F88

Q37660295-C912550D-53A3-4E1D-B6BC-477ED8F7AD2C

P2860

Q37660295-0D13F52D-CCCA-47B3-9B7F-1EEAFE45405D

Q37660295-1945BC28-8692-45CA-8A01-A482FF883490

Q37660295-1B95D283-4E5A-4822-8EAD-02E2D52D8FA8

Q37660295-1FD20A7E-9511-42C4-88D6-121ABF4C2B2A

Q37660295-22CF2906-31B1-434E-85A8-F893826550E2

Q37660295-26972B09-0D90-4A99-8E37-F840774D7736

Q37660295-26F5729F-1D4F-4955-9ACF-E0F666F35CFA

Q37660295-2FDFCCB8-87AB-44C2-A55D-5055E8DA2AF9

Q37660295-32652440-A49C-4066-A724-BB9B0EED5004

Q37660295-375D39BC-E86C-42A6-AA3F-8A57EA443195

P304

Q37660295-0A7E03A6-4150-4067-BC71-3099015B135A

P31

Q37660295-4A1273D6-5433-45DB-B822-A419E8210401

P356

Q37660295-F3FAEA2C-C7E9-40FE-960A-042182EDC1AD

P407

Q37660295-D731BA72-047F-4C7D-AC8A-8476F3F43899

P433

Q37660295-5AD46CC6-714E-4C64-9686-49123C1E52C6

P478

Q37660295-76E26220-C087-4926-A485-D1AF4E8DB348

P577

Q37660295-8920D5A9-793C-48F9-8F08-3F07B973E6A9

P5875

Q37660295-2CE649AD-76DD-4997-B32A-673CA07B7D52

P698

Q37660295-2A169FF5-6BF9-4563-AA61-8B110DB421B3

P932

Q37660295-DFE0495A-FFC3-4EDD-A65B-C107E29175E7

P356

ONCOTARGET.1620

P1433

P1476

EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma.

@en

P2093

Bakhos A Tannous

http://www.w3.org/2001/XMLSchema#string

Bas Tops

http://www.w3.org/2001/XMLSchema#string

David P Noske

http://www.w3.org/2001/XMLSchema#string

Esther Hulleman

http://www.w3.org/2001/XMLSchema#string

Gertjan J L Kaspers

http://www.w3.org/2001/XMLSchema#string

Jian Teng

http://www.w3.org/2001/XMLSchema#string

Judith Jeuken

http://www.w3.org/2001/XMLSchema#string

Lotte Hiddingh

http://www.w3.org/2001/XMLSchema#string

Pieter Wesseling

http://www.w3.org/2001/XMLSchema#string

Sandra H Boots-Sprenger

http://www.w3.org/2001/XMLSchema#string

P2860

Sequence, recombinant expression and tissue localization of two novel extracellular matrix proteins, fibulin-3 and fibulin-4

EFEMP1 binds the EGF receptor and activates MAPK and Akt pathways in pancreatic carcinoma cells

Significance analysis of microarrays applied to the ionizing radiation response

Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma.

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Fibulin-3 is uniquely upregulated in malignant gliomas and promotes tumor cell motility and invasion

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents.

P304

363-374

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.1620

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260093309

http://www.w3.org/2001/XMLSchema#string

P698

24495907

http://www.w3.org/2001/XMLSchema#string

P932

3964213

http://www.w3.org/2001/XMLSchema#string